- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06791642
Laparoscopic Parastomal Hernia Repair Using the Sandwich Technique: (APOLLO)
Laparoscopic Parastomal Hernia Repair Using the Sandwich Technique: a Multicenter Study of Clinical Outcomes, Recurrence Rates, and Quality of Life Improvements
Study Overview
Status
Conditions
Detailed Description
Study Description: Improving Surgical Outcomes for Parastomal Hernia Repair
Parastomal hernias (PSHs) are a common and challenging complication that occurs in patients with stomas-surgically created openings in the abdomen used to divert waste. These hernias can cause discomfort, limit daily activities, and require surgical intervention to repair. Despite advancements in surgical techniques, PSH repair remains a complex issue, with high recurrence rates and varying outcomes.
This study investigates the effectiveness of a specific surgical approach called the "sandwich technique" for PSH repair. This method uses two layers of mesh to reinforce the abdominal wall and provide extra support around the stoma, aiming to reduce the likelihood of hernia recurrence while maintaining the function of the stoma. The first layer of mesh is placed directly around the stoma in a "keyhole" fashion, and the second layer reinforces the surrounding abdominal wall in a broader "overlay" configuration.
The research evaluates multiple aspects of this technique:
- Effectiveness: Measuring recurrence rates over time, particularly for patients with larger hernias or recurrent hernias.
- Safety: Assessing complications such as infections, seromas (fluid accumulation), or mesh-related issues.
- Quality of Life (QoL): Using patient-reported surveys to evaluate how the repair impacts physical comfort, stoma care, body image, and social activities.
- Comparison of Materials: Analyzing outcomes for two commonly used mesh types-Parietex™ Composite Mesh and Synecor™ Hybrid Mesh-to determine if material selection affects long-term results.
The study incorporates the European Hernia Society (EHS) classification system to categorize hernia types based on size and complexity. This allows for a tailored approach to treatment and helps identify which patients may benefit most from specific surgical strategies.
While the sandwich technique has shown promise in reducing recurrence rates and enhancing recovery, this research seeks to provide stronger evidence to guide surgeons in selecting the best techniques and materials for PSH repair. By focusing on patient-centered outcomes and refining surgical methods, the study aims to improve long-term results and overall quality of life for individuals living with stomas.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Naples, Italy, 80131
- francesco Pizza
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Specify the criteria for participating in the study in a bulleted list under each category heading ("Inclusion Criteria" and "Exclusion Criteria"). Include only one item per bullet.
Exclusion Criteria:
Age below 18 years.
- Patients with recurrent parastomal hernia repairs requiring an open surgical approach.
- Evidence of active abdominal infection or sepsis at the time of surgery.
- Known allergies to mesh materials used in the study (e.g., Parietex™ or Synecor™).
- Presence of significant comorbidities making laparoscopic surgery unsafe (e.g., advanced cardiopulmonary disease).
- Pregnancy at the time of surgery.
- Inability to provide informed consent or comply with follow-up requirements.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Group 1: Parietex™ Composite Mesh
Group 1: Parietex™ Composite Mesh This group consisted of patients who had their PSH repair performed using the Parietex™ Composite Mesh, a dual-layer synthetic mesh designed to promote tissue integration while minimizing the risk of adhesions. The Parietex™ mesh is composed of a macroporous structure on one side, which facilitates tissue ingrowth, and an anti-adhesive barrier on the other side to reduce complications such as bowel adhesions or erosion. This mesh was applied using the sandwich technique, combining a keyhole configuration around the stoma with an overlay reinforcement of the abdominal wall. |
The sandwich technique was performed laparoscopically according to minimally invasive principles. Pneumoperitoneum was typically established using a Veress needle if the subcostal region was free from previous surgical scarring. For patients with prior extensive abdominal surgeries, a small laparotomy was performed to place the first 10-mm trocar directly under vision, ensuring safe entry into the peritoneal cavity. A 30° laparoscope was used throughout the procedure for enhanced visualization of the operative field. Trocar placement was designed to optimize access and ergonomics. The primary trocar was placed either in the periumbilical region or in the left or right flank, depending on the patient's anatomy and stoma location. Mesh used:1. Parietex™ Composite Mesh (Medtronic, USA): A multifilament polyester mesh with an anti-adhesive collagen barrier to minimize visceral adhesions. The sandwich technique was performed laparoscopically according to minimally invasive principles. Pneumoperitoneum was typically established using a Veress needle if the subcostal region was free from previous surgical scarring. For patients with prior extensive abdominal surgeries, a small laparotomy was performed to place the first 10-mm trocar directly under vision, ensuring safe entry into the peritoneal cavity. A 30° laparoscope was used throughout the procedure for enhanced visualization of the operative field. Trocar placement was designed to optimize access and ergonomics. The primary trocar was placed either in the periumbilical region or in the left or right flank, depending on the patient's anatomy and stoma location. Mesh use Synecor™ Hybrid Mesh (BD, USA): A macroporous mesh combining polypropylene with a bioresorbable layer that degrades over time, leaving a durable support structure to promote tissue integration. |
|
Group 2: Synecor™ Hybrid Mesh
This group included patients who underwent PSH repair using the Synecor™ Hybrid Mesh, an advanced composite mesh that combines biologic and synthetic materials. The Synecor™ mesh integrates a bioresorbable layer for improved biocompatibility and tissue integration with a synthetic layer to enhance long-term strength and durability. It also incorporates anti-adhesive properties to minimize the risk of complications. Similar to the Parietex™ group, this mesh was used in the sandwich technique to provide dual-layer reinforcement. Key features of this group:
|
The sandwich technique was performed laparoscopically according to minimally invasive principles. Pneumoperitoneum was typically established using a Veress needle if the subcostal region was free from previous surgical scarring. For patients with prior extensive abdominal surgeries, a small laparotomy was performed to place the first 10-mm trocar directly under vision, ensuring safe entry into the peritoneal cavity. A 30° laparoscope was used throughout the procedure for enhanced visualization of the operative field. Trocar placement was designed to optimize access and ergonomics. The primary trocar was placed either in the periumbilical region or in the left or right flank, depending on the patient's anatomy and stoma location. Mesh used:1. Parietex™ Composite Mesh (Medtronic, USA): A multifilament polyester mesh with an anti-adhesive collagen barrier to minimize visceral adhesions. The sandwich technique was performed laparoscopically according to minimally invasive principles. Pneumoperitoneum was typically established using a Veress needle if the subcostal region was free from previous surgical scarring. For patients with prior extensive abdominal surgeries, a small laparotomy was performed to place the first 10-mm trocar directly under vision, ensuring safe entry into the peritoneal cavity. A 30° laparoscope was used throughout the procedure for enhanced visualization of the operative field. Trocar placement was designed to optimize access and ergonomics. The primary trocar was placed either in the periumbilical region or in the left or right flank, depending on the patient's anatomy and stoma location. Mesh use Synecor™ Hybrid Mesh (BD, USA): A macroporous mesh combining polypropylene with a bioresorbable layer that degrades over time, leaving a durable support structure to promote tissue integration. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
hernia recurrence rate
Time Frame: 12 months
|
defined as clinical or radiological confirmation of a recurrent parastomal hernia.
|
12 months
|
|
hernia recurrence rate
Time Frame: 24 months
|
defined as clinical or radiological confirmation of a recurrent parastomal hernia.
|
24 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Surgical Site Infections (SSIs)
Time Frame: 1 months
|
The occurrence of surgical site infections was assessed as a critical indicator of postoperative morbidity.
SSIs were monitored through clinical evaluations, including signs of redness, swelling, warmth, pain, and discharge at the surgical site, and were managed according to established guidelines.
|
1 months
|
|
Surgical Site Infections (SSIs)
Time Frame: 3 months
|
The occurrence of surgical site infections was assessed as a critical indicator of postoperative morbidity.
SSIs were monitored through clinical evaluations, including signs of redness, swelling, warmth, pain, and discharge at the surgical site, and were managed according to established guidelines.
|
3 months
|
|
Surgical Site Infections (SSIs)
Time Frame: 6 months
|
The occurrence of surgical site infections was assessed as a critical indicator of postoperative morbidity.
SSIs were monitored through clinical evaluations, including signs of redness, swelling, warmth, pain, and discharge at the surgical site, and were managed according to established guidelines.
|
6 months
|
|
Surgical Site Infections (SSIs)
Time Frame: 12 months
|
The occurrence of surgical site infections was assessed as a critical indicator of postoperative morbidity.
SSIs were monitored through clinical evaluations, including signs of redness, swelling, warmth, pain, and discharge at the surgical site, and were managed according to established guidelines.
|
12 months
|
|
Surgical Site Infections (SSIs)
Time Frame: 24 months
|
The occurrence of surgical site infections was assessed as a critical indicator of postoperative morbidity.
SSIs were monitored through clinical evaluations, including signs of redness, swelling, warmth, pain, and discharge at the surgical site, and were managed according to established guidelines.
|
24 months
|
|
Mesh-Related Complications:Bowel Adhesions
Time Frame: until 24 months
|
Abnormal fibrous connections between the bowel and mesh, potentially causing pain or obstruction.
|
until 24 months
|
|
Mesh-specific complications : Mesh Migration:
Time Frame: until 24 month
|
Displacement of the mesh from its intended position.
|
until 24 month
|
|
Mesh-Related Complications:Mesh Erosion into the Stoma
Time Frame: until 24 months
|
Displacement of the mesh from its intended position.
|
until 24 months
|
|
Number of Participants with Postoperative Seroma Formation
Time Frame: 1 months
|
Accumulation of fluid at the surgical site, confirmed through physical examination or imaging.
|
1 months
|
|
Number of Participants with Postoperative Seroma Formation:
Time Frame: 3 months
|
Accumulation of fluid at the surgical site, confirmed through physical examination or imaging.
|
3 months
|
|
Number of Participants with Postoperative Seroma Formation:
Time Frame: 6 months
|
Accumulation of fluid at the surgical site, confirmed through physical examination or imaging.
|
6 months
|
|
Number of Participants with Postoperative Seroma Formation:
Time Frame: 12 months
|
Accumulation of fluid at the surgical site, confirmed through physical examination or imaging.
|
12 months
|
|
Number of Participants with Postoperative Seroma Formation:
Time Frame: 24 months
|
Accumulation of fluid at the surgical site, confirmed through physical examination or imaging.
|
24 months
|
|
Number of Participants with Postoperative Hematoma Formation
Time Frame: 1 months
|
Localized blood collection near the surgical site, evaluated clinically or with imaging as needed.
|
1 months
|
|
Number of Participants with Postoperative Hematoma Formation
Time Frame: 3 months
|
Localized blood collection near the surgical site, evaluated clinically or with imaging as needed.
|
3 months
|
|
Number of Participants with Postoperative Hematoma Formation
Time Frame: 6 months
|
Localized blood collection near the surgical site, evaluated clinically or with imaging as needed.
|
6 months
|
|
Number of Participants with Postoperative Hematoma Formation
Time Frame: 12 months
|
Localized blood collection near the surgical site, evaluated clinically or with imaging as needed.
|
12 months
|
|
Number of Participants with Postoperative Hematoma Formation
Time Frame: 24 months
|
Localized blood collection near the surgical site, evaluated clinically or with imaging as needed.
|
24 months
|
|
Number of Participants with Postoperative Bowel Obstruction
Time Frame: until 24 months
|
Episodes of bowel obstruction were recorded based on patient symptoms (e.g., abdominal distension, vomiting) and confirmed using imaging studies
|
until 24 months
|
Collaborators and Investigators
Investigators
- Study Director: francesco pizza, PhD, Azienda Sanitaria Locale Napoli 2 Nord
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20252819
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Explanation for Not Sharing Individual Participant Data (IPD)
Individual participant data (IPD) will not be shared due to the following considerations:
- Patient Confidentiality: Sharing IPD may risk breaching participant privacy, even if anonymized, particularly given the detailed nature of surgical and clinical data.
- Ethical Constraints: The consent obtained from participants does not include provisions for data sharing beyond the scope of this study.
- Regulatory Compliance: Institutional policies and local regulations may limit the sharing of sensitive health information.
- Data Ownership: The data is collected across multiple centers, and permissions for sharing may vary depending on institutional agreements and data governance policies.
- Limited Generalizability of Raw Data: Given the study's small sample size and highly specialized focus, the broader utility of the raw IPD for external analysis is limited.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parastomal Hernia
-
Fudan UniversityNot yet recruitingParastomal Hernia
-
Sykehuset Innlandet HFRecruiting
-
Swissmed HospitalMedical University of GdanskCompleted
-
Aalborg University HospitalCompleted
-
Fundació Institut de Recerca de l'Hospital de la...Unknown
-
Oulu University HospitalHelsinki University Central Hospital; Päijänne Tavastia Central Hospital; Vaasa... and other collaboratorsCompletedParastomal Hernia
-
Consorci Sanitari IntegralNot yet recruiting
-
Azienda Sanitaria Locale Napoli 2 NordRecruitingParastomal HerniaItaly
-
Clayton PetroCompletedParastomal HerniaUnited States
Clinical Trials on Laparoscopic Parastomal Hernia Repair Using the Sandwich Technique
-
University Hospital, Gentofte, CopenhagenEthicon, Inc.WithdrawnHernia | Abdominal Hernia
-
Instituto do Cancer do Estado de São PauloNot yet recruiting
-
Cairo UniversityCompleted
-
Zagazig UniversityCompleted
-
Helwan UniversityEnrolling by invitation
-
Fudan UniversityTongji Hospital; Qilu Hospital of Shandong University; Tianjin Medical University... and other collaboratorsNot yet recruitingPancreatic Neuroendocrine Tumor | Solid Pseudopapillary Tumor of the Pancreas | Pancreatic Tumor, Benign
-
Cairo UniversityCompleted
-
Nijznevartovsk County Clinical HospitalCompletedHernia, VentralRussian Federation
-
Ain Shams UniversityActive, not recruiting
-
Anchora MedicalCompleted